Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 May 2008

Thorax. Published Online First: 1 February 2008. doi:10.1136/thx.2007.086785
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society.

Papers

Markers Of Treatment Failure In Hospitalized Community-Acquired Pneumonia

Rosario Menéndez 1*, Manuela Cavalcanti 2, Soledad Reyes 3, José Mensa 4, Raquel Martinez 3, María A Marcos 4, Xavier Filella 4, Michael Niederman 5 and Antoni Torres 6

1 Hospital Universitario La Fe, Spain
2 research fellow from Pavilhao Pereira Filho, PPG Pneumologia-UFRGS, Brazil
3 Hospital Universitario La Fe, Valencia, Spain
4 Hospital Clinic, Barcelona, Spain
5 Winthrop University Hospital, Mineola, New York, United States
6 Hospital Clinic, Spain

* To whom correspondence should be addressed. E-mail: rmenend{at}separ.es.

Accepted 12 December 2007


Abstract

Background: Lack of response to treatment in community-acquired pneumonia (CAP) worsens outcome. We evaluated the systemic cytokine profile -TNF{alpha}, IL1, IL6, IL8 and IL10- C-reactive protein (CRP) and procalcitonin (PCT) in patients with CAP who had treatment failure.

Methods: A prospective study was performed in hospitalized patients with CAP. Cytokines, PCT and CRP measurements were obtained on day 1 and after 72 hours of treatment. Treatment failure was the endpoint evaluated, with separation of those with early (≤72hours) or late failure.

Results: 453 patients were included: 84 (18 %) had treatment failure, of which 38(8 %) were early failure. The median levels of IL-6, PCT and CRP on days 1 and 3 and the median level of IL-8 on day 1 were significantly higher in patients with any treatment failure. Logistic regression analysis demonstrated that values above the following cut-off points for IL-6 (≥169 pg/ml), IL-8 (≥14)and CRP (≥21.9 mg/dl), on day 1 had independent predictive value for any treatment failure after adjustment for initial severity; relative risks (OR) found were 1.9, 2.2 and 2.6 respectively. Increased levels for CRP and PCT at day 1 were also independent predictors for early failure. Increased levels for IL-6 and CRP were the best predictors of late failure.

Conclusions: Serum levels of CRP, IL-6 and PCT on days 1 and 3 are independently associated with a higher risk of any treatment failure. Low levels of PCT and CRP on day one have a high negative predictive value for early failure

Keywords: c reactive protein, cytokine, failure, pneumonia, procalcitonin


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Airwaves
Wisia Wedzicha
Thorax 2008 63: 387. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Menendez, R, Martinez, R, Reyes, S, Mensa, J, Polverino, E, Filella, X, Esquinas, C, Martinez, A, Ramirez, P, Torres, A (2009). Stability in community-acquired pneumonia: one step forward with markers?. Thorax 64: 987-992 [Abstract] [Full Text]  
  • Lim, W S, Baudouin, S V, George, R C, Hill, A T, Jamieson, C, Le Jeune, I, Macfarlane, J T, Read, R C, Roberts, H J, Levy, M L, Wani, M, Woodhead, M A, Pneumonia Guidelines Committee of the BTS Standard, (2009). BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64: iii1-iii55 [Full Text]  
  • Brown, J. S (2009). Biomarkers and community-acquired pneumonia. Thorax 64: 556-558 [Full Text]  
  • Menendez, R, Martinez, R, Reyes, S, Mensa, J, Filella, X, Marcos, M A, Martinez, A, Esquinas, C, Ramirez, P, Torres, A (2009). Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 64: 587-591 [Abstract] [Full Text]  
  • Singanayagam, A., Chalmers, J.D., Hill, A.T. (2009). Severity assessment in community-acquired pneumonia: a review. QJM 102: 379-388 [Abstract] [Full Text]  
  • Bruns, A. H. W., Oosterheert, J. J., Hak, E., Hoepelman, A. I. M. (2008). Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J 32: 726-732 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs